Coiled Therapeutics PLC · LSE:COIL
Coiled Therapeutics — Roquefort Investments — IPO Roadshow (March 2021)
9 slides from Coiled Therapeutics's IPO roadshow presentation, March 2021
Slide 1: Investor Presentation March 2021
INVESTOR PRESENTATION March 2021 www.roquefortinvest.com
Slide 2: Disclaimer
Disclaimer NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. This presentation is the sole responsibility of the dir
Slide 3: Overview
Overview • Roquefort Investments plc was incorporated in August 2020 • Highly experienced Board with proven track record in bringing companies to market and completing value accretive transactions • Listing on the London Stock Exchange (Standard List) in March 2021 (ROQ) • Raising up to £1 million a
Slide 4: Strategy
Strategy • Roquefort Investments is seeking to acquire an early stage business in the medical biotechnology sector • Suitable acquisition targets will be identified through the Board’s network in the UK, Continental Europe and Australia • To pursue opportunities to acquire biotech business focused o
Slide 5: Board of Directors / Founders
Board of Directors / Founders Stephen West: Executive Chairman Dr Michael Stein: Director Designate+ § over 26 years of financial and corporate experience gained § medical doctor (Honours) and biochemist (First Class in public practice, oil and gas, mining and investment Honours) from the University
Slide 6: The Biotechnology Sector
The Biotechnology Sector • Science-driven industry sector that makes use of living organisms and molecular biology to produce healthcare-related products and therapeutics, or to run processes • Best known for its increasingly important role in the fields of medicine and pharmaceuticals • Biotechnolo
Slide 7: Capital Structure
Capital Structure Cash £’m Number % SHARES Directors & founders 0.12 12,400,000 38% IPO 1.00 20,000,000 62% Costs+ (0.18) - - TOTAL 0.94 32,400,000 100% WARRANTS Seed & founders (10p) 12,000,000 1 for 2 IPO Warrants (10p) 10,000,000 Broker Warrants (1p) 1,500,000 Broker Placing Warrants (10p)++ 480,
Slide 8: Pathway to Listing and Beyond
Pathway to Listing and Beyond • Advisers appointed to manage the listing process • Prospectus lodged with UKLA • IPO fundraising being undertaken in March 2021 • Expected to list on Standard List of London Stock Exchange in March 2021 (ticker ROQ) • Target a suitable acquisition (RTO) in 2021 Corpor
Slide 9: Big results require big ambitions
www.roquefortinvest.com “Big results require big ambitions” Heraclitus